UK markets closed

TRACON Pharmaceuticals, Inc. (TCON)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.8100+0.1000 (+5.85%)
At close: 04:00PM EDT
1.7700 -0.04 (-2.21%)
After hours: 06:48PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
12,045
12,045
0
346
0
Operating expenses
Research development
12,277
12,277
13,888
11,146
8,198
Selling general and administrative
6,666
6,666
14,006
17,547
8,025
Total operating expenses
18,943
18,943
27,894
28,693
16,223
Operating income or loss
-6,898
-6,898
-27,894
-28,347
-16,223
Interest expense
7,304
7,304
994
318
545
Total other income/expenses net
10,614
10,614
-247
-2
-7
Income before tax
-3,588
-3,588
-29,135
-28,667
-16,775
Income from continuing operations
-3,588
-3,588
-29,135
-28,667
-16,775
Net income
-3,588
-3,588
-29,135
-28,667
-16,775
Net income available to common shareholders
-3,588
-3,588
-29,135
-28,667
-16,775
Basic EPS
-0.44
-
-1.39
-1.66
-1.87
Diluted EPS
-0.44
-
-1.39
-1.66
-1.87
Basic average shares
28,424
-
20,919
17,253
8,984
Diluted average shares
28,424
-
20,919
17,253
8,984